Back

Efficacy of percutaneous stellate ganglion block according to ventricular arrhythmia cycle length: a post-hoc sub-analysis of the STAR study

30 August 2024 (12:15 - 12:30)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award Session in Arrhythmias, Pacing and Electrophysiology Antiarrhythmic Drug Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Enrico Baldi

Fondazione IRCCS Policlinico San Matteo, Pavia (Italy)

3 More presentations in this session

Presentation thumbnail
PPGAF-score: a photoplethysmographic risk prediction tool for developing atrial fibrillation
Doctor L. Freyer (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Generative adversarial networks (GANs) to produce synthetic 12-lead electrocardiogram signals for specific and rare diseases: a novel, powerful tool towards clinical advancements
Doctor P. Pantelidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Risk factors for fatal ventricular arrhythmias in heart failure with preserved ejection fraction: a report from the CHART-2 Study
Doctor T. Ito (Sendai, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award Session in Arrhythmias, Pacing and Electrophysiology
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical determinants of percutaneous stellate ganglion block (PSGB) effectiveness in patients with electrical storm
thumbnail
Congress Presentation
Why, when, and how to perform autonomic modulation for electrical storm management
thumbnail
Congress Presentation
Practical tricks for Percutaneous Stellate Ganglion Block (PSGB) in patients with electrical storm

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources